ClinicalTrials.govpublic full text
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations
carcinoma, non-small-cell lung, tyrosine kinase inhibitor, vitamin c, non-small cell lung cancer, progression-free survival, overall survival, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898118
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.